Cognizant, Nvidia tap generative AI to boost drug discoveries

Cognizant said it aims to give clients access to a suite of model-making services, including pretrained models, cutting-edge frameworks, and APIs, that offers clients the quickest path to train and customize enterprise models using their proprietary data.
Read The Rest at :